Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$164.52 - $238.84 $2.8 Million - $4.07 Million
17,027 New
17,027 $4.03 Million
Q2 2022

Aug 05, 2022

SELL
$204.13 - $302.4 $1.86 Million - $2.75 Million
-9,110 Reduced 34.99%
16,923 $3.62 Million
Q1 2022

May 12, 2022

SELL
$255.51 - $362.11 $4.85 Million - $6.88 Million
-18,986 Reduced 42.17%
26,033 $7.39 Million
Q4 2021

Feb 10, 2022

BUY
$351.38 - $448.68 $6.76 Million - $8.63 Million
19,233 Added 74.59%
45,019 $17 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $6.87 Million - $8.45 Million
18,446 Added 251.31%
25,786 $10.6 Million
Q2 2021

Aug 12, 2021

BUY
$294.17 - $371.65 $2.16 Million - $2.73 Million
7,340 New
7,340 $2.72 Million
Q2 2020

Aug 13, 2020

SELL
$118.84 - $189.72 $997,780 - $1.59 Million
-8,396 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$98.9 - $178.34 $830,364 - $1.5 Million
8,396 New
8,396 $1.06 Million
Q1 2019

May 08, 2019

SELL
$104.82 - $146.73 $230,603 - $322,806
-2,200 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$105.09 - $137.23 $231,198 - $301,906
2,200 New
2,200 $249,000
Q2 2018

Aug 02, 2018

SELL
$102.37 - $117.25 $673,082 - $770,918
-6,575 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$98.19 - $115.2 $645,599 - $757,440
6,575 New
6,575 $702,000
Q4 2017

Feb 09, 2018

SELL
$100.43 - $118.09 $1.04 Million - $1.23 Million
-10,400 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $1.01 Million - $1.14 Million
10,400
10,400 $1.12 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.